KeyCorp Has Lowered Expectations for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its price target reduced by stock analysts at KeyCorp from $120.00 to $110.00 in a report released on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. KeyCorp’s price target points to a potential upside of 29.59% from the stock’s current price.

Several other equities analysts have also recently commented on HQY. Barrington Research reissued an “outperform” rating and issued a $112.00 price target on shares of HealthEquity in a research report on Friday, March 14th. JMP Securities lifted their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Raymond James increased their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 25th. Finally, Royal Bank of Canada boosted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $113.69.

HealthEquity Stock Up 0.3 %

Shares of HQY opened at $84.88 on Monday. The company’s 50-day simple moving average is $104.90 and its 200-day simple moving average is $95.76. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. HealthEquity has a 1 year low of $65.01 and a 1 year high of $115.59. The stock has a market capitalization of $7.36 billion, a PE ratio of 77.87, a P/E/G ratio of 1.60 and a beta of 0.62.

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several institutional investors have recently added to or reduced their stakes in the stock. Intech Investment Management LLC grew its stake in shares of HealthEquity by 59.5% in the 3rd quarter. Intech Investment Management LLC now owns 21,064 shares of the company’s stock valued at $1,724,000 after purchasing an additional 7,859 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in HealthEquity by 7.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 484,782 shares of the company’s stock valued at $39,679,000 after buying an additional 33,523 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in HealthEquity by 1.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock valued at $86,909,000 after buying an additional 14,532 shares during the period. Raymond James Trust N.A. raised its position in HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after buying an additional 132 shares during the last quarter. Finally, Citigroup Inc. raised its position in HealthEquity by 73.0% during the 3rd quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock worth $8,357,000 after buying an additional 43,084 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.